Cafeína: Factor protector en la diabetes

Abdul-Ghani, M.; DeFronzo, R.; Williams, K.; Stern, M. (2007). What is the best predictor of future type 2 diabetes? Diabetes Care, 30: 1544-1548. https://doi.org/10.2337/dc06-1331

American Diabetes Association (2010). Diagnosis and classification diabetes mellitus. Diabetes care, 28: 37-42. https://doi.org/10.2337/diacare.28.suppl_1.S37

Bhandari, B.K.; Feliers, D.; Duraisamy, S. et al. (2001). Insulin regulation of protein translation repressor 4E-BP1, an eIF4E-binding protein, in renal epithelial cells. Kidney Inernational, 59: 866-875. https://doi.org/10.1046/j.1523-1755.2001.059003866.x

Benowitz, N.L. (1990). Clinical pharmacology of caffeine. Annual Review Medical, 41: 377-388. https://doi.org/10.1146/annurev.me.41.020190.001425

Blanco, A. (2006). Química biológica. Ed. El Ateneo.

Breyer, M.D.; Böttinger, E.; Brosius, F.C.; et al. (2005). Mouse models of diabetic nephropathy. Journal of American Society Nephrol., 16: 27-45. https://doi.org/10.1681/ASN.2004080648

Campos, H. y Baylin, A. (2007). Coffe consumption and risk of type 2 diabetes and heart disease. Nutrition Review, 65(4): 173-179. https://doi.org/10.1301/nr.2007.apr.173-179

Castro, L. (1977). Diseño experimental sin estadística: Usos y restricciones en su aplicación a las ciencias de la conducta. 2a edición (9ª reimpresión, 1992). México: Editorial Trillas.

Cheraskin, E. y Ringsdorf, W.M.Jr. (1967). Efecto of caffeine versus placebo supplementation on blood-glucose concentration. Lancet., 2: 1299-1300. https://doi.org/10.1016/S0140-6736(67)91593-0

Cheraskin, E. y Ringsdorf, W.M.Jr. (1968). Blood-glucose levels after caffeine. Letters to the editor. Lancet., 2: 689. https://doi.org/10.1016/S0140-6736(68)92550-6

Currie, R.A.; Walker, K.S.; Gray, A. et al. (1999). Role of phosphatidylinositol 3,4,5-trisphosphate in regulating the activity and localization of 3-phosphoinositide-dependent protein kinase. Biochemical Journal., 337: 575- 583. https://doi.org/10.1042/bj3370575

Dawson-Saunders, B. y Trapp, R.G. (2005). Bioestadística Médica. 5ª Ed. México: El Manual Moderno.

De Fronzo, R.A. (2004). Pathogenesis of type 2 diabetes mellitus. Medical Clinical North America, 88: 787-832. https://doi.org/10.1016/j.mcna.2004.04.013

De Jong, J.W.; De Jonge, R.; Keijzer, E. y Brandamante, S. (2000). The role of adenosine in preconditioning. Pharmacological therapeutics, 87: 141-149. https://doi.org/10.1016/S0163-7258(00)00044-9

Denaro, C.P.; Brown, C.R.; Wilson, M.; Jacob, P.III y Benowitz, N.L. (1990). Dose-dependence of caffeine metabolism with repeated dosing. Clinical Pharmacological Therapeutics, 48: 277-285. https://doi.org/10.1038/clpt.1990.150

Donovan, J.L. y DeVane, C.L. (2001). A primer on caffeine pharmacology and its drug interaction in clinical psychopharmacology. Psychopharmacology Bulletin, 35 (3): 30-48. https://doi.org/10.64719/pb.4252

Duff, G. (2007). Expert scientific group in phase on clinical trials. Final report. 26-30.

Egawa, T.; Hamada, T.; Karaike, X.; Kameda, N.; Masuda, S.; Iwanaka, N. y Hayashi, T. (2010). Caffeine activates preferentially a1-Isoform of 5'-AMP -ac- tivated protein kinase in rat skeletal muscle. Acta Physiologica. En prensa.

Federación Mexicana de Diabetes. (2010). Diabetes en números: Los números de la diabetes en México. México: FMD, A.C.

Feinberg, L.J.; Sandberg, H.; De Castro, O. y Bellet, S. (2008). Effects of coffee ingestion on oral glucose tolerance curves in normal human subjects. Metabolism., 17: 916-922. https://doi.org/10.1016/0026-0495(68)90158-3

Flagg, T.; Enkvetchakul, D.; Koster, J. y Nichols, C. (2010). Muscle KATP Channels: recent Insights to energy sensing and myoprotection. American Physi- ological society. Physiological Review, 90: 799-820. https://doi.org/10.1152/physrev.00027.2009

Flakoll, P.J.; Carlson, M.G. y Cherrington, A.D. (2003). Acción fisiológica de la insulina. En: Le Roith, D.; Taylor, S.I. y Olefsky, J.M. (editores), Diabetes mellitus, fundamentos y clínica. 2ª ed. México: Mc Graw Hill.

Fredholm, B.B. (2010). Adenosine receptors as drug targets. Exp Cell Res., 316 (8): 1284-1288. https://doi.org/10.1016/j.yexcr.2010.02.004

Frode, T.S. y Madeiros, Y.S. (2008). Animals models to test drugs with potential antidiabetic activity. Journal of Ethnopharmacology, 115: 173-183. https://doi.org/10.1016/j.jep.2007.10.038

Fuhr, U. y Rost, K.L. (1994). Simple and reliable CYP1A2 phenotyping by the paraxanthine/caffeine ratio in plasma and in saliva. Pharmacogenetics, 4: 109-116. https://doi.org/10.1097/00008571-199406000-00001

Giovannone, B.; Scaldaferri, M.L.; Federici, M. et al. (2000). Insulin receptor substrate (IRS) transduction system: distinct and overlapping signaling poten- tial. Diabetes Metabol Research Review, 16: 434-441. https://doi.org/10.1002/1520-7560(2000)9999:9999<::AID-DMRR159>3.0.CO;2-8

Gong, H.; Simmons, M.S.; Tashkin, D.P.; Hui, K.K. y Lee, E.Y. (1986). Bronchodilator effects of caffeine in coffee. Chest., 89: 335-342.

Graham, T.E.; Sathasivam, P.; Rowland, M.; Marko, N.; Greer, F. y Battram, D. (2001). Caffeine ingestion elevates plasma insulin response in humans during an oral glucose tolerance test. Canadian Journal Physiological Pharmacol., 79: 559-565. https://doi.org/10.1139/y01-026

Han, B.; Hao, C.; Tchekneva, E.; Wang, Y.; Lee, C.; Ebraim, B.; Harris, R.; Kern,T.; Wasserman, D.; Breyer, M. y Qi, Z. (2008). Markers of glycemic control in the mouse: Comparision of six hours and overweight fasted blood glucose to HbA1c. American Journal of Physiological Endocrinology Metabol., 295 (4): 981-986. https://doi.org/10.1152/ajpendo.90283.2008

Hanley, A.; Williams, K.; González, C.; Agostino, R.; Wagenknecht, L.; Stern, M. y Haffner, S. (2003). Prediction of type 2 diabetes using simple measures of insulin resistance. Diabetes, 52: 463-469. https://doi.org/10.2337/diabetes.52.2.463

Higdon, J.V. y Frei, B. (2006). Coffe and health: a review of recent human research. Cit. Rev. Food Science Nutrition, 46 (2): 101-123.

Hino, A.; Adachi, H.; Enomoto, M.; Furuki, K.; Shigetoh, Y.; Ohtsuka, M.; Kumagae, S.; Hirari, Y.; Satoh, A. y Imaizumi, T. (2007). Habitual coffee but not green tea consumption is inversely associated with metabolic syndrome: an epidemiological study in a general Japanese population. Diabe- tes Research Clinical Practice, 76 (3): 383-389. https://doi.org/10.1016/j.diabres.2006.09.033

Horrigan, L.A.; Kelly, J.P. y Connor, T.J. (2006). Inmunomodulatory effects of caffeine: Friend or foe? Journal of Pharmacology and therapeutics, 111: 877- 892. https://doi.org/10.1016/j.pharmthera.2006.02.002

International Coffee Organization (2008). History Coffee Statistics. London, UK: International Coffee Organization. Disponible en: http://eurlex.europa. eu/LexUriServ/site/es/oj/2002/.pdf.

Iso, H.; Date, C.; Wakai, K.; Fukui, M.; et al. (2006). The relation between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults. American College of Physicians, 144 (8): 554-562. https://doi.org/10.7326/0003-4819-144-8-200604180-00005

Joshida, Y.; Hayakawa, M. y Etsuo, N. (2008). Evaluation of the antioxidant effects coffee and its components using biomarkers Hidroxyoctadecadienoic Acid and Isoprostane. Journal of Oleo Science, 57 (12): 691-697. https://doi.org/10.5650/jos.57.691

Kagami, K.; Morita, H.; Onda, K.; Hirano, T. y Oka, K. (2008). Protective effect of caffeine on streptozotocin-induced beta-cell damage in rats. Journal of Pharmacy and pharmacology, 60: 1161-1165. https://doi.org/10.1211/jpp.60.9.0007

Khan, C.R. (1994). Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes, 43: 1066-1084. https://doi.org/10.2337/diab.43.8.1066

Kanety, H.; Moshe, S. y Shafrir, E. (1994). Hyperinsulinemia induces a reversible impairment in insulin receptor function leading to diabetes in te sand rat model of non- insulindependent diabetes mellitus. Proc. Natl. Acad. Sci. USA, 91: 1853-1857. https://doi.org/10.1073/pnas.91.5.1853

Katsumata, K.; Katsumata, K.Jr. y Katsumata, Y. (1992). Protective effect of diltiazem hydrochloride on the occurrence of alloxan or streptozotocin induced diabetes in rats. Hormone Metabolic Research, 24: 508-510. https://doi.org/10.1055/s-2007-1003376

Kerry, B.; Goralski, C.; y Sinal, J. (2007). Type 2 diabetes and cardiovascular disease: getting to the fat of the matter. Canadian Journal Physiology and Pharmacology, 85: 113-132. https://doi.org/10.1139/y06-092

King, H.; Aubert, R. y Herman, W. (1998). Global burden of diabetes, 1995- 2025. Prevalence, numerical estimates and projections. Diabetes Care, 21: 1414-1431. https://doi.org/10.2337/diacare.21.9.1414

Kempf, K.; Herder, Ch.; Erlund, I.; Kolb, H.; Martin, S. y Koening, W. (2010). Effects of coffee consuption on subclinical inflamation and other risk factors for type 2 diabetes: A clinical trial. The American Journal of Clinical Nutrition, 91: 950-957. https://doi.org/10.3945/ajcn.2009.28548

Kirk, R.F. (1982). Experimental design: procedures for the behavioral sciences. 2nd ed. Brooks/Cole.

Knowler, W.C.; Barrett-Connor, E.; Fowler, S.E.; et al. (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal Medical, 346: 393-403. https://doi.org/10.1056/NEJMoa012512

Kohjiro, U.; Fruman, D.A.; et al. (2002). Molecular balance between the regulatory and catalytic subunits of phosphoinositide 3-Kinase regulates cell signaling and survival. Molecular Cell Biology, 22: 965-977. https://doi.org/10.1128/MCB.22.3.965-977.2002

Larsen, M.O.; Rolin, B.; Gotfredsen, C.F.; Carr, R.D. y Holst, J.J. (2004). Reduction of beta cell mass: partial insulin secretor y compensation from the residual beta cell population in the nicotinamide-streptozotocin Göttingen minipig ofter oral glucose in vivo and in the perfused pancreas. Diabetology, 47: 1873-1878. https://doi.org/10.1007/s00125-004-1546-9

Lazar, M.A. (2005). How obesity causes diabetes: not a tell tale. Science, 307: 373-375. https://doi.org/10.1126/science.1104342

Lundsberg, L.S. (1998). Coffeine consumption. En: Spiller, G.A. (ed.), Caffeine. Boca Raton, FL: CRC Pr. https://doi.org/10.1201/9781420050134.ch9

Masiello, P.; Broca, C.; Gross, R.; Roye, M. y Manteghetti, M. (1998). Experimental NIDDM development of a new model in adult rats administred streptozotocin and nicotinamide. Diabetes, 47. https://doi.org/10.2337/diab.47.2.224

Masiello, P. (2006). Animal models of type 2 diabetes with reduced pancreatic B-cell mass. The International Journal of Biochemistry and Cell Biology, 38: 873-893. https://doi.org/10.1016/j.biocel.2005.09.007

Mathis, D.; Vence, L.; Benoist, C. (2001). B-cell death during progression to diabetes. Diabetes Care, 414: 792-798. https://doi.org/10.1038/414792a

Matsuda, M. y DeFronzo, R. (1999). Insulin sensitivity indices obtained from oral glucosa tolerance testing. Diabetes Care, 22: 1462-1470. https://doi.org/10.2337/diacare.22.9.1462

Mendívil, A. y Sierra, A. (2005). Acción insulínica y resistencia a la insulina: aspectos moleculares. Revista de la Facultad de Medicina Nacional de Co- lombia, 53 (4): 235-243.

Meyts, P.D. (2000). Isulin and its receptor: structure, function and evolution. Bio Essays, 26: 1351-1356. https://doi.org/10.1002/bies.20151

Morgan, N.G.; Cable, H.C.; Newcombe, N.R. y Williams, G.T. (1994). Treatment of cultured pancreatic B-cells with streptozotocin induces cell death by apoptosis. Bioscience Reprint., 14: 243-250. https://doi.org/10.1007/BF01209729

Muniyappa, R.; Lee, S.; Chen, H. y Quon, M. (2007). Current approaches for assesing insulin sensitivity and resistance in vivo: advantages. Limitations and appropiate usage. American Journal of Physiologcal Endocrinology Metabol., 294: 15-26.

Muniyappa, R.; Chen, H.; Muzumadar, R.; Einstein, F.; Yan, X.; Yue, L.; Barzilai, N. y Quon, M. (2009). Comparision between surrogate indexes of insulin sensitivity/ resistance and hyperinsulinemic euglycemic clamp estimates in rats. American Journal of Physiological Endocrinology Metabol., 297: 1023-1029. https://doi.org/10.1152/ajpendo.00397.2009

Myers, M.G. y White, M.F. (2003). The new elements of insulin signaling. Insulin receptor substrate-1 and proteins with SH2 domains. Diabetes, 42: 643-650.

Nawrot, P.; Jordan, S.; Eastwood, J.; Rotstein, J.; Hugenholtz, A. y Feeley, M. (2003). Effects of caffeine on human health. Fodd Addition Contamination, 20 (1): 1-30. https://doi.org/10.2337/diabetes.42.5.643

Norma Oficial Mexicana (NOM-015-SSA2-1994). Para la prevención, tratamiento y control de la diabetes mellitus en la atención primaria. Disponible en http://www.guanajuato.gob.mx/ssg/prescripcion/normas/015SSA24. pdf.

Norma Oficial Mexicana (NOM-062-ZOO-1999). Especificaciones técnicas para la producción, cuidado y uso de animales de laboratorio. Disponible en http://www.guanajuato.gob.mx/ssg/prescripcion/normas.

Pass, D. y Freeth, G. (1993). The rat. An ZCCART, 6: 1-4.

Pirola, L.; Johnston, A.M. y Van Obberghen, E. (2004). Modulation of insulin action. Diabetologia, 47: 170-184. https://doi.org/10.1007/s00125-003-1313-3

Pons, S.; Asano, T.; Glasheen, E.; et al. (1995). The structure and function of p55PIK reveals a new regulatory subunit for phosphatidylinositol 3-kinase. Molecular Cell Biology, 15: 4453-4465. https://doi.org/10.1128/MCB.15.8.4453

Ross, G.W.; Abbott, R.D.; Petrovitch, H.; et al. (2000). Association of coffee and caffeine intake with the risk of parkinson disease. JAMA, 283: 26742679. https://doi.org/10.1001/jama.283.20.2674

Sakamoto, K.; Aschenbach, W.G.; Hirshman, M.F.; et al. (2003). Akt signaling in skeletal muscle: regulation by exercise and passive stretch. American Journal of Physiology Endocrinology Metabol., 285: 1081-1088. https://doi.org/10.1152/ajpendo.00228.2003

Schenk, S.; Saberi, M. y Olfesky, J.M. (2008). Insulin sensitivity: modulation by nutrients and inflamation. Journal of Clinical Investigation, 118: 29923002. https://doi.org/10.1172/JCI34260

Shafrir, E. y Ziv, E. (1998). Cellular mechanism of nutritionally induced insulin resistance: The dessert rodent Psamomys obesus and other animals in which insulin resistance leads to determental outcome. Journal of Basic Clinical Physiology and Pharmacology, 9: 347-385. https://doi.org/10.1515/JBCPP.1998.9.2-4.347

Shafrir, E.; Ziv, E. y Mosthaf, L. (1999). Nutritionally induced insulin resistance and receptor defect leading to B-cell failure in animal models. Ann. New York Academic Science, 892: 223-246. https://doi.org/10.1111/j.1749-6632.1999.tb07798.x

Shafrir E. (2007). Animal models of diabetes. Frontiers in research. 2nd Ed. Estados Unidos: CRC Press Taylor Francis. https://doi.org/10.1201/9781420009453

Shoelson, S.E.; White, M.F. y Kahn, C.R. (1998). Tryptic activation of the insulin receptor. Proteolytic truncation of the alfa-subunit releases the beta- subunit from inhibitory control. Journal of Biologgical Chemestry, 263: 4852-4860. https://doi.org/10.1016/S0021-9258(18)68864-7

Skolnik, E.Y.; Lee, C.H.; Batzer, A.; et al. (1993). The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: Implications for insulin control of ras signalling. EMBO Journal, 12: 1929-1960.

Smith, B.; Wingard, D.L.; Smith, T.C.; Kritz-Silverstein, D. y Barret-Connor, E. (2006). Does coffee consumption reduce the risk of type 2 diabetes in individuals with impaired glucose? Diabetes Care, 29 (11): 2385-2390. https://doi.org/10.2337/dc06-1084

Srinivasan, K. y Ramarao, P. (2007). Animal models in type 2 diabetes research. Indian Journal of Medical Research, 125: 451-472.

Stalmach, A.; Mullen, W.; Barron, D.; Uchida, K.; Yokota, T.; Cavin, C.; Steling, N.; Williamson, G. y Crozier, A. (2009). Metabolite profiling of hidroxycinnamate derivatives in plasma and urine after the ingestion of coffee by humans: Identification of biomarkers of coffee consumption. Drug Metabolism and Disposition, 37: 1-10.

Szkudelski, T. (2001). The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res., 50 (6): 537-546. https://doi.org/10.33549/physiolres.930111

Tuomilehto, J.; Lindstrom, J.; Eriksson, J.G.; et al. (2001). Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New England Journal of Medicine, 344: 1343-1350. https://doi.org/10.1056/NEJM200105033441801

Tuomilehto, J.; Hu, G.; Bidel, S.; Lindström, J. y Jousilahti, P. (2004). Coffee consumption and risk of type 2 diabetes mellitus among middle-aged finish men and women. JAMA, 291 (10): 1213-1219. https://doi.org/10.1001/jama.291.10.1213

Van Dam, R.M. y Hu, F.B. (2005). Coffee consumption and risk of type 2 diabetes: A systematic review. JAMA, 294: 97-104. https://doi.org/10.1001/jama.294.1.97

Van Dam, R.M.; Manson, J.E.; Willett, W.C. y Hu, F. (2006). Coffe, caffeine, and risk of type 2 diabetes: a prospective cohort study in younger and middle-aged U.S. women. Diabetes Care, 29 (2): 398-403. https://doi.org/10.2337/diacare.29.02.06.dc05-1512

Weyer, C.; Bogardus, C.; Mott, D.M. y Pratley, R.E. (1999). The natural history of insulin secretory disfunction and insulin resistance in the phatogenesis of type 2 diabetes mellitus. Journal of Clinical Investigation, 104: 787-794. https://doi.org/10.1172/JCI7231

Wojtaszewski, J.F.; Nielsen, P.; Kiens, B.; et al. (2001). Regulation of glycogen synthase kinase-3 in human skeletal muscle: effects of food intake and bicycle exercise. Diabetes, 50: 265-269. https://doi.org/10.2337/diabetes.50.2.265

World Health Organization (2009). Screening for type 2 diabetes. Report of a World Health Organization and International Diabetes Federation Meeting, WHO/NMH/MNC/03.1.

Yoshida, Y.; Haykawa, M. y Niki, E. (2008). Evaluation of the antioxidant effects of coffee and its components using the biomarkers hydroxyoctadecadienoic acid and isoprostane. Journal of Oleo Science, 12: 691-697. https://doi.org/10.5650/jos.57.691

Zheng, D.;McLean, P.; Pohnert, S.; Knight, J.; Olson, A.; Winder, W. y Dhom, G. (2001). Regulation of muscle GLUT -4 transcription by AMP- activated protein kinase. Journal of Applicated Physiology, 91: 1073- 1083. https://doi.org/10.1152/jappl.2001.91.3.1073